Skip to main content
Rallis India Ltd logo

Rallis India Ltd — Investor Relations & Filings

Ticker · RALLIS ISIN · INE613A01020 LEI · 335800HI7I928BFJB442 BSE.NS Manufacturing
Open in API
Filings indexed 1,589 across all filing types
Latest filing 2022-11-12 Regulatory Filings
Country IN India
Listing BSE.NS RALLIS

About Rallis India Ltd

https://www.rallis.com/

Rallis India Ltd, a subsidiary of Tata Chemicals and a member of the Tata Group, specializes in providing comprehensive crop care solutions. The company's core business activities encompass the manufacturing and marketing of a diverse portfolio of agrochemicals, including insecticides, fungicides, and herbicides. Additionally, it maintains a significant presence in the seeds business, developing high-yielding hybrids for crops such as maize, paddy, and pearl millet. Rallis also offers plant growth nutrients and soil conditioners to enhance agricultural productivity. With a robust research and development framework and a vast distribution network, the company serves both domestic and international markets, exporting products to over 70 countries. Its operations are supported by integrated manufacturing facilities and a commitment to sustainable agricultural practices, positioning it as a key partner in the global agricultural value chain.

Recent filings

Filing Released Lang Actions
Please find enclosed the intimation letters dated November 11, 2022 received from our Registrar and Transfer Agent - TSR Consultants Private Limited, regarding loss of share certificates ....
Regulatory Filings Classification · 100% confidence The document is an official communication addressed to stock exchanges regarding the loss of share certificates of the company Rallis India Limited. It includes notices from the Registrar and Transfer Agent about lost/misplaced share certificates and the issuance of duplicate certificates. The document references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 39(3), which pertains to share certificate loss and related disclosures. There is no financial data, earnings information, management discussion, or report publication mentioned. The content is a regulatory announcement about share certificate status and related procedural notices. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2022-11-12 English
Related Party Transaction
Regulatory Filings Classification · 95% confidence The document is a disclosure of related party transactions for the half year ended September 30, 2022, submitted pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations. It contains detailed tabular data on transactions between the company and related parties, including values approved by the audit committee and remarks on approvals. The document is an official regulatory disclosure related to compliance and transparency requirements rather than a full financial report or management discussion. It is not an annual or interim report, earnings release, or audit report. The document is a regulatory filing providing mandated disclosures to stock exchanges and regulators. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length (12,447 characters) and detailed data confirm it is not a brief announcement or certification but a formal regulatory disclosure.
2022-11-03 English
Pursuant to Regulation 23(9) of Listing Regulations, please find enclosed the disclosures of related party transactions and balances for the half year ended September 30, 2022. The aforesaid ....
Regulatory Filings Classification · 95% confidence The document is a disclosure of related party transactions for the half year ended September 30, 2022, submitted pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations. It contains detailed tabular data on transactions with related parties, including values approved by the audit committee and remarks on approvals. The document is an official regulatory disclosure filing to stock exchanges, not a full financial report or management discussion. It is not an annual or interim report, earnings release, or audit report. It is a regulatory compliance filing specific to related party transactions, which fits best under the category of Regulatory Filings (RNS) as it does not match other more specific categories and is a regulatory announcement.
2022-11-03 English
Transcript of Analysts/Institutional Investor Meet/Con. Call
Call Transcript Classification · 100% confidence The document is a transcript of an earnings conference call for Rallis India Limited for the second quarter and half year ended September 30, 2022. It includes detailed discussions by company executives about financial results, business performance, industry conditions, and outlook. The text explicitly mentions it is a transcript of the Q2 FY23 Earnings Conference Call held on October 20, 2022. The content includes financial figures, business segment performance, and forward-looking statements typical of earnings call transcripts. Therefore, the document fits the category of a Call Transcript (CT). The document length is substantial (15,000 characters), and it contains the full transcript, not just an announcement or summary, supporting a high confidence classification as CT.
2022-10-27 English
Further to our letter dated October 11, 2022, we enclose herewith a copy of the transcript of the Analyst/Investors Call on the Unaudited Financial Results of the Company for the second ....
Call Transcript Classification · 100% confidence The document is a transcript of an earnings conference call for Rallis India Limited for the second quarter and half year ended September 30, 2022. It includes detailed discussions by company executives on financial results, business performance, market conditions, and outlook, as well as a Q&A session. The presence of a full transcript of the call, including management commentary and financial details, clearly identifies this as a Call Transcript (CT). The document is lengthy (15,000 characters) and contains substantive content, not just an announcement or summary, confirming it is not an Earnings Release (ER) or Report Publication Announcement (RPA).
2022-10-27 English
This has reference to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. In accordance with the said Regulation(s), please find enclosed ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges notifying them of a scheduled meeting with analysts and institutional investors. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 30(6), which pertains to disclosure of events or information. The content is about the schedule of an investor meeting and explicitly states that no unpublished price sensitive information will be shared. The document is short (1651 characters) and does not contain any financial data, results, or detailed presentations. It is an announcement of an upcoming investor meeting rather than a report or transcript. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2022-10-22 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.